moxonidine has been researched along with Cardiovascular Diseases in 6 studies
moxonidine: structure given in first source
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Optimal cardiovascular prevention after preeclampsia should be further explored." | 3.11 | Differential effects of renin-angiotensine-aldosteron system inhibition, sympathoinhibition and low sodium diet on blood pressure in women with a history of preeclampsia: A double-blind, placebo-controlled cross-over trial (the PALM study). ( Franx, A; Groenhof, TKJ; Paauw, ND; Spiering, W; Titia Lely, A; Veerbeek, JHW; Verhaar, MC; Zoet, GA, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zoet, GA | 1 |
| Paauw, ND | 1 |
| Veerbeek, JHW | 1 |
| Groenhof, TKJ | 1 |
| Spiering, W | 1 |
| Verhaar, MC | 1 |
| Franx, A | 1 |
| Titia Lely, A | 1 |
| Lambert, EA | 1 |
| Sari, CI | 1 |
| Eikelis, N | 1 |
| Phillips, SE | 1 |
| Grima, M | 1 |
| Straznicky, NE | 1 |
| Dixon, JB | 1 |
| Esler, M | 1 |
| Schlaich, MP | 1 |
| Head, GA | 1 |
| Lambert, GW | 1 |
| Rayner, B | 1 |
| Rupp, H | 1 |
| Jacob, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Assessment of the Effect of Moxonidine and Diet on Cardiac, Renal and Endothelial Function in Young Subjects With Abdominal Obesity[NCT01180231] | Phase 4 | 77 participants (Anticipated) | Interventional | 2010-09-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for moxonidine and Cardiovascular Diseases
| Article | Year |
|---|---|
Selective imidazoline agonist moxonidine plus the ACE inhibitor ramipril in hypertensive patients with impaired insulin sensitivity: partners in a successful MARRIAGE?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Cardiovascular Dis | 2004 |
2 trials available for moxonidine and Cardiovascular Diseases
| Article | Year |
|---|---|
Differential effects of renin-angiotensine-aldosteron system inhibition, sympathoinhibition and low sodium diet on blood pressure in women with a history of preeclampsia: A double-blind, placebo-controlled cross-over trial (the PALM study).
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Cardiovascular Diseases; Cross-Over | 2022 |
[Cardiovascular and metabolic diseases. Imidazolin-antagonists and the sympathetic nervous system].
Topics: Antihypertensive Agents; Cardiovascular Diseases; Humans; Imidazoles; Metabolic Diseases; Placebos; | 1998 |
3 other studies available for moxonidine and Cardiovascular Diseases
| Article | Year |
|---|---|
Effects of Moxonidine and Low-Calorie Diet: Cardiometabolic Benefits from Combination of Both Therapies.
Topics: Adolescent; Adult; Antihypertensive Agents; Caloric Restriction; Cardiovascular Diseases; Humans; Im | 2017 |
[Study examines prescriptions for hypertension. Physicians adhering to guidelines very well].
Topics: Antihypertensive Agents; Cardiovascular Diseases; Germany; Guideline Adherence; Humans; Hypertension | 2003 |
Excess catecholamines and the metabolic syndrome: should central imidazoline receptors be a therapeutic target?
Topics: Animals; Antihypertensive Agents; Cardiovascular Diseases; Catecholamines; Energy Intake; Energy Met | 1995 |